RSS   Newsletter   Contact   Advertise with us

Zai Lab appoints Billy Cho as CFO

Staff Writer | Beijing, China | March 6, 2018
Zai LabZai Lab Limited, a biopharmaceutical company, announced the appointment of Billy Cho as chief financial officer.
Mr. Cho joins from Citigroup where he was the Managing Director and Head of Asia Healthcare Investment Banking.

Mr. Cho has nearly 18 years of experience in the healthcare industry across the US and Asia.

Based in Hong Kong for the past seven years, Mr. Cho was responsible for healthcare client coverage at Citigroup across the Asia Pacific region and led many important healthcare transactions in China including Zai Lab’s US IPO.

Prior to this, he was based in New York in healthcare M&A investment banking and also spent time in corporate development for a pharmaceutical services company.

Mr. Cho started his career at Ernst & Young performing financial audits of US-based healthcare companies.

Mr. Cho earned his MBA from the Wharton School of the University of Pennsylvania.